Translate
Viking Therapeutics Inc
About
Viking Therapeutics Inc (NASDAQ:VKTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026
Mar 26 2026
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
Feb 11 2026
Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Feb 4 2026
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
Jan 12 2026
Viking Therapeutics Announces Publication of Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in the Journal Obesity